Cargando…
Organ Regeneration Through Stem Cells and Tissue Engineering
Loss of organ and tissue due to injuries or diseases led to the development of regenerative therapies to decrease reliance on organ transplantations. It deals with employing the self-renewal ability of stem cells to differentiate into numerous lineages to assist in providing effective treatment for...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973391/ https://www.ncbi.nlm.nih.gov/pubmed/36865965 http://dx.doi.org/10.7759/cureus.34336 |
_version_ | 1784898514439897088 |
---|---|
author | Ajmal, Laiba Ajmal, Sidra Ajmal, Maleeha Nawaz, Gul |
author_facet | Ajmal, Laiba Ajmal, Sidra Ajmal, Maleeha Nawaz, Gul |
author_sort | Ajmal, Laiba |
collection | PubMed |
description | Loss of organ and tissue due to injuries or diseases led to the development of regenerative therapies to decrease reliance on organ transplantations. It deals with employing the self-renewal ability of stem cells to differentiate into numerous lineages to assist in providing effective treatment for a range of various injuries and diseases. Regenerative engineering of organs or tissues represents an ever-expanding field that is aimed at developing biological replacements for dysfunctional organs or injured tissues. The critical issue, however, with the engineering of organs outside the human body is the insufficient availability of human cells, the absence of a suitable matrix with the same architecture and composition as the target tissue, and the maintenance of organ viability in the absence of the blood supply. The issue regarding the maintenance of the engineered organ viability can be solved using bioreactors consisting of mediums with defined chemical composition, i.e., nutrients, cofactors, and growth factors that can successively sustain the target cell’s viability. Engineered extracellular matrices and stem cells to regenerate organs outside the human body are also being used. Clinically, various adult stem cell therapies are readily under practice. This review will focus on the regeneration of organs through various types of stem cells and tissue engineering techniques. |
format | Online Article Text |
id | pubmed-9973391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-99733912023-03-01 Organ Regeneration Through Stem Cells and Tissue Engineering Ajmal, Laiba Ajmal, Sidra Ajmal, Maleeha Nawaz, Gul Cureus Transplantation Loss of organ and tissue due to injuries or diseases led to the development of regenerative therapies to decrease reliance on organ transplantations. It deals with employing the self-renewal ability of stem cells to differentiate into numerous lineages to assist in providing effective treatment for a range of various injuries and diseases. Regenerative engineering of organs or tissues represents an ever-expanding field that is aimed at developing biological replacements for dysfunctional organs or injured tissues. The critical issue, however, with the engineering of organs outside the human body is the insufficient availability of human cells, the absence of a suitable matrix with the same architecture and composition as the target tissue, and the maintenance of organ viability in the absence of the blood supply. The issue regarding the maintenance of the engineered organ viability can be solved using bioreactors consisting of mediums with defined chemical composition, i.e., nutrients, cofactors, and growth factors that can successively sustain the target cell’s viability. Engineered extracellular matrices and stem cells to regenerate organs outside the human body are also being used. Clinically, various adult stem cell therapies are readily under practice. This review will focus on the regeneration of organs through various types of stem cells and tissue engineering techniques. Cureus 2023-01-29 /pmc/articles/PMC9973391/ /pubmed/36865965 http://dx.doi.org/10.7759/cureus.34336 Text en Copyright © 2023, Ajmal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Transplantation Ajmal, Laiba Ajmal, Sidra Ajmal, Maleeha Nawaz, Gul Organ Regeneration Through Stem Cells and Tissue Engineering |
title | Organ Regeneration Through Stem Cells and Tissue Engineering |
title_full | Organ Regeneration Through Stem Cells and Tissue Engineering |
title_fullStr | Organ Regeneration Through Stem Cells and Tissue Engineering |
title_full_unstemmed | Organ Regeneration Through Stem Cells and Tissue Engineering |
title_short | Organ Regeneration Through Stem Cells and Tissue Engineering |
title_sort | organ regeneration through stem cells and tissue engineering |
topic | Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973391/ https://www.ncbi.nlm.nih.gov/pubmed/36865965 http://dx.doi.org/10.7759/cureus.34336 |
work_keys_str_mv | AT ajmallaiba organregenerationthroughstemcellsandtissueengineering AT ajmalsidra organregenerationthroughstemcellsandtissueengineering AT ajmalmaleeha organregenerationthroughstemcellsandtissueengineering AT nawazgul organregenerationthroughstemcellsandtissueengineering |